NCT07676240 An Adapted Evidence-Based Coaching Program for Fathers and Their Young Children in the Context of Home Visiting
| NCT ID | NCT07676240 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Washington |
| Condition | Positive Parenting |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2026-06-15 |
| Primary Completion | 2029-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2026-06-15 with a primary completion date of 2029-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Father-child pairs (N=200; children ages 12-36 months) will be randomized to FIND-F or a waitlist control group. Assessments comparing the two groups will occur at baseline, end of program, and 6 months post-program. Our aims include: Aim 1: Evaluate the main impacts of FIND-F on the primary program target (fathers' supportive parenting) and related child and parent outcomes. Aim 2. Identify mechanisms of FIND-F's intervention effects. Aim 3. Examine variation by select child, father, and program measures.
Eligibility Criteria
Inclusion Criteria: * Identify as a father * Speak English or Spanish * Have a child between the ages of 12-36 months who lives with you * Be enrolled in Akin services Exclusion Criteria: * No additional exclusion criteria
Contact & Investigator
Holly Schindler, PhD
PRINCIPAL INVESTIGATOR
University of Washington
Frequently Asked Questions
Who can join the NCT07676240 clinical trial?
This trial is open to participants of all sexes, aged 12 Months or older, studying Positive Parenting. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07676240 currently recruiting?
Yes, NCT07676240 is actively recruiting participants. Contact the research team at hschindl@uw.edu for enrollment information.
Where is the NCT07676240 trial being conducted?
This trial is being conducted at Seattle, United States.
Who is sponsoring the NCT07676240 clinical trial?
NCT07676240 is sponsored by University of Washington. The principal investigator is Holly Schindler, PhD at University of Washington. The trial plans to enroll 200 participants.